DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES 120 :
Total Turn.

RegenLab France Receives Prestigious EU-EIB Innovation Champion Award

2024-06-13 11:26:00

PARIS-SACLAY, France--()--RegenLab, a pioneering biotechnology company specializing in the research, development, and manufacturing of patented cell and tissue engineering medical devices, has been honored with the “Innovation Champion Award” by the European Investment Bank (EIB) at the European Convention Center in Luxembourg.

This prestigious award recognizes RegenLab France’s commitment to “reshoring” by establishing a state-of-the-art biotechnology factory in Paris-Saclay and its innovation, the REGENMATRIX® PRP-HA. This next-generation product combines Platelet-Rich Plasma (PRP) with cross-linked Hyaluronic Acid (HA) in a single tube, designed specifically to address the needs of patients with advanced grade III-IV knee osteoarthritis. Currently, a clinical study is underway in 16 university hospitals across France to demonstrate the effectiveness and safety of this groundbreaking treatment.

We are honored and delighted to receive this award from the European Investment Bank,” said Mr. Antoine Turzi, Founder & CEO of RegenLab France. “This recognition celebrates the successful completion of our French factory and our ongoing R&D efforts. Our goal is to innovate in cell therapies and enhance the well-being of patients, while supporting industry reshoring in France.”

RegenLab’s achievement not only highlights its dedication to advancing medical science but also underscores the pivotal role of the EIB in promoting innovation, its sustainable growth across Europe and its competitiveness worldwide.

About RegenLab

Based in Paris Saclay, RegenLab France is a company specialized in the R&D and manufacturing of tissue engineering medical devices supported by 100 patents. The Company’s solutions are commercialized in more than 90 countries. The core technology of the Company is manufacturing of medical devices for autologous platelet-rich plasma (PRP) & Tissue Engineering, consisting in reinjecting the patient’s own cells and platelets into tissue lesions in order to stimulate tissue healing. The RegenKit, CellularMatrix… brands,  have been CE marked EU-MDR 2017/745 and approved by US-FDA, CFDA & worldwide regulatory agencies;  they are routinely used for the treatment of a wide variety of indications including joint osteoarthritis, tendinopathies, woman health and dermo-aesthetics. The Company’s medical devices are also manufactured in the factory of Le Mont-sur-Lausanne (Switzerland) & New York (USA).


RegenLab France SAS | +33 1 77 44 60 60 | info@regenlab.com
Antoine Turzi | C.E.O.
Hubert de Pombriant I General Manager
Jean-Marc Biscarrat | Chief Financial Officer

RegenLab France receives prestigious EU-EIB Innovation Champion Award. Antoine Turzi, CEO and Founder of RegenLab, pictured between two officials of the European Investment Bank. (Photo: Business Wire)


Interfax Business Wire

People, Passion, Planet: Mary Kay Releases 2024 Sustainability Report
DCO Calls for Urgent Discussions with Member States, Digital Experts to Address Recent Global IT Outage’s Implications
LambdaTest Integrates with Netlify to Enhance Developer Workflows
Laserfiche Global Headquarters Achieves LEED Silver Certification
CSC and Palo Alto Networks Join Forces to Fortify Domain Security for Cortex XSOAR, XSIAM, and XPANSE Users and CSC Domain Registrar Clients
SLB to Accelerate Co-Development of AI-Driven Digital Platform for Aker BP
AtriCure Receives Regulatory Approval to Sell AtriClip® Devices in China
BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World
NIPPON KINZOKU’s Cold Profile Rolled Products Are Named "Fine Profile” to Strengthen Sales Expansion
Andersen Global Broadens Footprint in Czech Republic
Lifezone Metals Produces First-Ever Nickel, Copper and Cobalt from Kabanga Nickel Project
Mavenir Moves in on Market Leader Status in New Omdia Core Vendors Report
Following a Successful FDA Inspection, KBI Biopharma Extends and Expands Commercial Contract with Leading Global Pharmaceutical Company
Corpay Cross-Border Named the Official B2B FX Partner for AEG Presents UK in Europe
COOLMAX® EcoMade Fiber Makes Summer Games Debut in Paris
Faraday Adds Video Interface IP to Support All Advanced Planar Nodes on UMC Platform
Corona Cero Brings Same Seats as from Olympic Games Venues to Iconic Sunset Destinations Around the World
Join China Hi-Tech Fair 2024, Where Innovation Meets Global Opportunity
Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution
MSCI Strengthens Private Markets Leadership With Launch of 130 Indexes
Back to Top